HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emodin mitigates diesel exhaust particles-induced increase in airway resistance, inflammation and oxidative stress in mice.

Abstract
Clinical and experimental studies have reported that short-term exposure to particulate air pollution is associated with inflammation, oxidative stress and impairment of lung function. Emodin (1,3,8-trihydroxy-6-methylanthraquinone) has a strong antioxidant and anti-inflammatory actions. Therefore, in the present study, we evaluated the possible ameliorative effect of emodin on diesel exhaust particles (DEP)-induced impairment of lung function, inflammation and oxidative stress in mice. Mice were intratracheally instilled with DEP (20 μg/mouse) or saline (control). Emodin was administered intraperitoneally 1h before and 7h after pulmonary exposure to DEP. Twenty-four hours following DEP exposure, we evaluated airway resistance measured by forced oscillation technique, lung inflammation and oxidative stress. Emodin treatment abated the DEP-induced increase in airway resistance, and prevented the influx of neutrophils in bronchoalveolar lavage fluid. Similarly, lung histopathology confirmed the protective effect of emodin on DEP-induced lung inflammation. DEP induced a significant increase of proinflammatory cytokines in the lung including tumor necrosis factor α, interleukin 6 and interleukin 1β. The latter effect was significantly ameliorated by emodin. DEP caused a significant increase in lung lipid peroxidation, reactive oxygen species and a significant decrease of reduced glutathione concentration. These effects were significantly mitigated by emodin. We conclude that emodin significantly mitigated DEP-induced increase of airway resistance, lung inflammation and oxidative stress. Pending further pharmacological and toxicological studies, emodin may be considered a potentially useful pulmonary protective agent against particulate air pollution-induced lung toxicity.
AuthorsAbderrahim Nemmar, Suhail Al-Salam, Priya Yuvaraju, Sumaya Beegam, Badreldin H Ali
JournalRespiratory physiology & neurobiology (Respir Physiol Neurobiol) Vol. 215 Pg. 51-7 (Aug 15 2015) ISSN: 1878-1519 [Electronic] Netherlands
PMID26001677 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Cytokines
  • Muscarinic Agonists
  • Particulate Matter
  • Protein Kinase Inhibitors
  • Reactive Oxygen Species
  • Methacholine Chloride
  • Glutathione
  • Emodin
Topics
  • Airway Resistance (drug effects)
  • Animals
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Emodin (pharmacology, therapeutic use)
  • Glutathione (metabolism)
  • Lipid Peroxidation (drug effects)
  • Lung (metabolism)
  • Lung Diseases (chemically induced, drug therapy, pathology)
  • Methacholine Chloride (toxicity)
  • Mice
  • Mice, Inbred BALB C
  • Muscarinic Agonists (toxicity)
  • Oxidative Stress (drug effects)
  • Particulate Matter (toxicity)
  • Pneumonia (chemically induced, drug therapy)
  • Protein Kinase Inhibitors (pharmacology, therapeutic use)
  • Reactive Oxygen Species (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: